[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: MAPS: Psychedelic Related Scientific Publications
On Thu, 29 Apr 1999 10:31:18 -0700 (PDT), Matthew Baggott wrote:
>supports the theory that MDMA belongs to a separate pharmacological
>class of compounds. Although MDMA-induced anxiety has been reported,
>decreased anxiety appears to be a more typical effect of MDMA in humans.
>Therefore, I found it surprising that MDMA appeared anxiogenic in this and
>a previous study. One possible explanation is that the measurements of
>rodent behavior in this experimental paradigm are insensitive to
>serotonergic drugs which affect anxiety.
Hmm.. I would have said this is -exactly- what human subjective data
shows. I have spoken to a large number of MDMA users and would
say that the dose response recorded in this study is typical of human
experience.
MDMA Underdose - the threshold of this varies radically by person (perhaps
correlated to MDMA metabolism?), but in the "underdose" experience, people
feel highly agitated, nervous, anxious, etc etc. Often a small increase
in dosage of MDMA or 'boost' will dramatically change the subjective
experience.
I have been with people who were taking MDMA for their first time who
started with a low attack dose (30-50mg oral) to gauge their own sensitivity,
planning to take a strong boost (60-100mg) at T+75mins. In two cases I
witnessed, they experienced uncomfortable jitters, coldness, tension, and a
strong desire for the effects to stop. Although they had been told beforehand
to expect these effects, one of the people I spoke to said they were extremely
reluctant to take more, extrapolating that more MDMA = more anxiety. In these
instances, additional boosts of MDMA caused the anxiety to disappear
completely and the euphoric, empathic, happy effects kicked in.
In more experienced users, I have seen similar, but less dramatic
effects. Sometimes a user will take MDMA and after 60-90 mins realize
that they are not experiencing the desired effects. Often the 'not quite
enough' MDMA experience is pretty yucko. Many users find that
a small boost of MDMA (15-25mg) or possibly a small amount of some
other psychoactive (cannabis, lsd, mushrooms, 2cb, etc) shifts the
person out of the anxio-genic into the anxiolytic.
I would also say that in most (but not all) users, increased lifetime total
usage increases the anxiogenic effects and reduces the euphoric-empathic
effects.
But, overall, this study is a confirmation of a dose-response experience
that I was told about long before I had ever seen MDMA use in person.
earth
www.erowid.org
------------------
MAPS-Forum@xxxxxxxx, a member service of the Multidisciplinary Association
for Psychedelic Studies (to become a member, see www.maps.org/memsub.html).
To [un]subscribe, email the message text,
[un]subscribe maps-forum youraddress to majordomo@xxxxxxxx